21 Invest to acquire a majority stake in Prosol.

21 Invest, a private equity firm that offers funds and portfolio management services, agreed to acquire a majority stake in Prosol, an Italian company specializing in the development and production of yeast-based ingredients and nutraceutical supplements. Financial terms were not disclosed. “The partnership with 21 Invest marks a crucial step to accelerate the future of Prosol. We share an ambitious strategic plan aimed at creating a European leader in yeast-based nutraceutical solutions for animal and human health. We are fully aligned and ready to seize the opportunities ahead of us, strengthened by the support and experience of 21 Invest," Daniele Bonvicini, Prosol CEO.